IRCT138805012159N2
Completed
Phase 2
Evaluating the effect of Fluoxetine on symptoms and quality of life of patients with moderate to sever irritable bowel syndrome in adults.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Irritable bowel syndrome.
- Sponsor
- Isfahan University of Medical Sciences
- Enrollment
- 180
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •age 18\-65 years, IBS diagnosis through ROME II criteria, moderate to severe symptoms through severity of symptom questionnaire Exclusion criteria : Diagnosis of any organic disease related to symptoms during the study, psychological disorders Taking any other psychotropic drugs at the beginning or during the trial or taking a MAO\-inhibitor drugs during 2 weeks before entering to the trial, record of taking Fluoxetine for treatment of IBS in the past, Presence of any contraindications for taking Fluoxetine, low compliance, severe complications due to Fluoxetine, Pregnancy or breastfeeding at the beginning or during the trial
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effect of fluoxetine on clinical symptoms and echocardiographic findings in patients with mitral valve prolapse and generalized anxiety disorder.Condition 1: Generalized anxiety disorder. Condition 2: mitral valve prolapse.Generalized anxiety disorderMitral (valve) prolapseIRCT2014102819721N1Sabzevar University of Medical Science60
Recruiting
Phase 3
Evaluation of effect of fluoxetine on the clinical prognosis in patients with anterior ischemic optic neuropathy (AION)IRCT20181109041596N1Iran University of Medical Sciences100
Completed
Phase 3
Evaluation of effect of fluoxetine on the clinical prognosis in patients with Optic neuritisIRCT20200719048138N1Iran University of Medical Sciences100
Recruiting
Phase 4
Evaluating The effect of fluoxetine on severity of depressive and anxiety symptoms in hemodialysis patientsCondition 1: Depressive symptoms in hemodialysis patients. Condition 2: Anxiety symptoms in hemodialysis patients.Major depressive disorder, single episodeGeneralized anxiety disorderF41.1IRCT20220422054611N1Kerman University of Medical Sciences70
Not yet recruiting
Not Applicable
The effectiveness of fluoxetine on the treatment of adaptive spasm caused by anxietyAccommodative spasm.Disorders of accommodationH52.5IRCT20240617062160N1Shahid Beheshti University of Medical Sciences68